IDXX vs SUPN · P/E 40, rev $2.36B vs rev $426.8M
IDEXX Laboratories Inc (IDXX) versus Supernus Pharmaceuticals Inc (SUPN) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported SUPN revenue for 2026-06-30 was $426.8M. Net income was -$60.7M. SUPN currently screens at market cap $2.53B.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. SUPN currently screens at market cap $2.53B.
Not investment advice. Open the IDXX and SUPN stock pages for the full models.
Not investment advice.